Purchase Order 36C26326P0278
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on February 6, 2026, with a completion date of February 9, 2026, reflects no set-aside designation and represents a typical procurement structure...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 for TAVR (transcatheter aortic valve replacement) products. The contract, which was not set aside for any business category, is scheduled for completion by November 17, 2025, with performance occurring in Minneapolis, Minnesota. As the sole manufacturer of the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 23 (VISN 23). The contract, designated as a TAVR (transcatheter aortic valve replacement) award, does not utilize a set-aside designation and was awarded on July 23, 2025, with an ultimate completion date of the same day. The place of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (VISN 23) on December 12, 2025. The contract, classified as a transcatheter aortic valve replacement (TAVR) procurement, has an ultimate completion date of December 15, 2025 and will be performed in Minneapolis, Minnesota. This award represents a non-competitive,...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical device innovation, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on November 7, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota with an ultimate completion date of November 10, 2025. This award carries no set-aside designation and...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis), awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems on February 20, 2026, with an ultimate completion date of February 23, 2026. This contract contains no set-aside designation and represents a sole-source procurement reflecting Edwards Lifesciences LLC's exclusive manufacturing capability for these specialized...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota. This award represents no set-aside designation and reflects the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23) awarded Edwards Lifesciences LLC a $34,000 firm fixed-price purchase order for transcatheter aortic valve replacement (TAVR) systems on January 16, 2026, with an ultimate completion date of January 20, 2026. The contract, which carries no set-aside designation, supports the VA's mission to provide specialized cardiac care to veterans in the Minneapolis service area. Edwards Lifesciences LLC, a subsidiary of...
Edwards Lifesciences LLC was awarded a $34K firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of March 3, 2026. This award carries no set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the Department of Veterans Affairs' cardiac care mission. The contract reflects Edwards Lifesciences' established role as a critical supplier of advanced heart valve technologies to the VA healthcare system, specifically SAPIEN transcatheter valves and related cardiac implants used in minimally invasive aortic valve replacement procedures for eligible veteran patients. This purchase order is part of Edwards Lifesciences LLC's extensive contractual relationship with the VA, which includes over 200 prime federal contract awards since 2025 and two cornerstone indefinite delivery contracts valued at $7.45M across VISN 21 and VISN 15. The company, operating as a self-certified small disadvantaged business, maintains sole-source procurement arrangements across multiple Veterans Integrated Service Networks, positioning it as the primary framework supplier of specialized cardiovascular devices to support VA surgical programs. This individual purchase order exemplifies the routine procurement transactions executed under Edwards Lifesciences' broader contractual framework with the VA system.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--PROS V23 618 UNU BILL & REPLACE 255797 TAVR (DOS: 2/26/2026) (VA-26-00049178) 618-M64218 | 36C26326Q0412 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 | Award Notice 1/1 | 2/27/26, 12:48 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 2/26/26 |